Hongshuai Liu

Jinan, 250355, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Polydatin improves mitochondrial dynamics dysrhythmia by regulating BMAL1 to prevent and treat metabolic dysfunction-associated fatty liver disease.

Polydatin improves mitochondrial dynamics dysrhythmia by regulating BMAL1 to prevent and treat metabolic dysfunction-associated fatty liver disease.

Journal: Journal of ethnopharmacology

Published: March 17, 2026

Diosgenin Ameliorates Insulin Resistance in High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatotic Liver Disease Rats via the Adiponectin/ADIPOR1/APPL1 Pathway.

Diosgenin Ameliorates Insulin Resistance in High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatotic Liver Disease Rats via the Adiponectin/ADIPOR1/APPL1 Pathway.

Journal: Journal of agricultural and food chemistry

Published: November 14, 2025

Genetic evidence for a causal relationship between 179 lipid species and cognitive function and alzheimer's disease: a bidirectional Mendelian randomization study.

Genetic evidence for a causal relationship between 179 lipid species and cognitive function and alzheimer's disease: a bidirectional Mendelian randomization study.

Journal: European archives of psychiatry and clinical neuroscience

Published: April 07, 2025

Diosgenin alleviates lipid accumulation in NAFLD through the pathways of ferroptosis defensive and executive system.

Diosgenin alleviates lipid accumulation in NAFLD through the pathways of ferroptosis defensive and executive system.

Journal: The Journal of nutritional biochemistry

Published: August 26, 2024

Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation.

Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation.

Journal: Chemico-biological interactions

Published: August 21, 2024

Diosgenin ameliorating non-alcoholic fatty liver disease via Nrf2-mediated regulation of oxidative stress and ferroptosis.

Diosgenin ameliorating non-alcoholic fatty liver disease via Nrf2-mediated regulation of oxidative stress and ferroptosis.

Journal: Diabetes, obesity & metabolism

Published: June 06, 2024

Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway.

Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway.

Journal: International immunopharmacology

Published: April 13, 2024

Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway.

Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway.

Journal: European journal of pharmacology

Published: March 23, 2024

Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKα-Drp1/PINK1-Parkin signaling pathway.

Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKα-Drp1/PINK1-Parkin signaling pathway.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: November 20, 2023

Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver.

Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: September 21, 2023

Association between gastroesophageal reflux disease and stroke: a bidirectional Mendelian randomization study.

Association between gastroesophageal reflux disease and stroke: a bidirectional Mendelian randomization study.

Journal: Frontiers in neurology

Published: September 15, 2023

Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials.

Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials.

Journal: Phytotherapy research : PTR

Published: July 31, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026